A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin (JNJ-28431754) in Healthy Indian Volunteers
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics (ie, how the body affects the
drug) and pharmacodynamics (ie, how the drug affects the body) of 2 different doses of
canagliflozin (JNJ-28431754) in healthy Indian volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.